在终端阶段心力衰竭中定义心脏功能恢复在单细胞分辨率下
Junedh M Amrute1,2, Lulu Lai3,2, Pan Ma1
1Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Nature cardiovascular research
|August 16, 2023
概括
心脏衰竭后的心脏恢复是罕见的. 这项研究确定了巨细胞和纤维细胞中RUNX1下调是恢复的关键因素,建议它作为治疗点.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 在心力衰竭中恢复心脏功能是一个关键的,但不太了解的治疗目标.
- 左心室辅助装置 (LVAD) 植入提供了一个独特的模型来研究心脏恢复.
研究的目的:
- 为了确定与LVAD植入后心脏恢复相关的细胞特异性转录特征.
- 调查RUNX1在心脏恢复中的作用.
主要方法:
- 单核RNA测序对心力衰竭患者的心脏样本进行了测序,这些患者在LVAD后恢复或没有恢复,以及来自非患病的捐赠者.
- 在基中对巨细胞和纤维细胞中RUNX1进行了扰.
- 通过BET抑制诱导小鼠的心脏恢复,并分析基因表达和染色质可访问性.
主要成果:
- 鉴定出了明显的细胞特异性转录恢复特征,特别是在巨细胞和纤维细胞中.
- 炎症特征与恢复有负相关性,而RUNX1下调与心脏功能改善有关.
- 在体和体内实验表明,调节RUNX1活动可以重复或影响恢复特征.
结论:
- 心脏恢复代表了一种独特的生物状态,其特点是特定的细胞和分子变化.
- RUNX1被确定为促进心力衰竭中心脏恢复的潜在治疗标.
更多相关视频
09:29Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
7.5K
10:37Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
Published on: March 14, 2021
6.5K
相关概念视频
Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
